# Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab

> **NCT02000102** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 14 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Intravitreal Injection of Aflibercept

## Key facts

- **NCT ID:** NCT02000102
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02000102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02000102, "Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02000102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*